Joshua Bilenker
E561041
Joshua Bilenker is an American oncologist and biotech executive best known for founding and leading Loxo Oncology, a precision medicine company focused on targeted cancer therapies.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Joshua Bilenker canonical | 1 |
Statements (28)
| Predicate | Object |
|---|---|
| instanceOf |
biotech executive
ⓘ
biotechnology company ⓘ oncologist ⓘ person ⓘ |
| countryOfCitizenship | United States of America ⓘ |
| educatedAt |
Duke University School of Medicine
NERFINISHED
ⓘ
Johns Hopkins University NERFINISHED ⓘ |
| employer | Loxo Oncology NERFINISHED ⓘ |
| fieldOfWork |
cancer drug development
ⓘ
oncology ⓘ oncology ⓘ precision medicine ⓘ precision medicine ⓘ targeted cancer therapies ⓘ |
| founded | Loxo Oncology NERFINISHED ⓘ |
| hasAcademicDegree | Doctor of Medicine ⓘ |
| hasExpertise |
biopharmaceutical industry leadership
ⓘ
clinical drug development ⓘ clinical oncology ⓘ |
| knownFor | precision oncology drug development ⓘ |
| notableFor |
founding Loxo Oncology
ⓘ
leadership in targeted cancer therapy development ⓘ |
| notableWork | development of targeted therapies for genetically defined cancers at Loxo Oncology ⓘ |
| occupation |
biotechnology executive
ⓘ
oncologist ⓘ |
| positionHeld |
chief executive officer of Loxo Oncology
ⓘ
founder of Loxo Oncology ⓘ |
| workLocation | United States of America ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
subject surface form:
Loxo Oncology